These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 28465239

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.
    Larsen A, Holm R, Pedersen ML, Müllertz A.
    Pharm Res; 2008 Dec; 25(12):2769-77. PubMed ID: 18592356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH, Hanley T, Porter CJ, Larson I, Boyd BJ.
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations.
    Siqueira SD, Müllertz A, Gräeser K, Kasten G, Mu H, Rades T.
    AAPS J; 2017 Mar; 19(2):587-594. PubMed ID: 28070714
    [Abstract] [Full Text] [Related]

  • 10. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY, Trevaskis NL, Porter CJ.
    Mol Pharm; 2013 Jul 01; 10(7):2601-15. PubMed ID: 23697606
    [Abstract] [Full Text] [Related]

  • 11. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y, Williams HD, Nguyen TH, Saunders J, Ford L, Charman SA, Scammells PJ, Porter CJ.
    Mol Pharm; 2015 Jun 01; 12(6):1980-91. PubMed ID: 25905624
    [Abstract] [Full Text] [Related]

  • 12. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW, Porter CJ, Boyd BJ.
    J Pharm Sci; 2013 Feb 01; 102(2):565-78. PubMed ID: 23242691
    [Abstract] [Full Text] [Related]

  • 13. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K, Hawley A, Jannin V, Pouton C, Boyd BJ.
    Eur J Pharm Biopharm; 2018 Sep 01; 130():236-246. PubMed ID: 29981444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
    Paulus F, Holm R, Stappaerts J, Bauer-Brandl A.
    Eur J Pharm Sci; 2024 Jun 01; 197():106765. PubMed ID: 38608735
    [Abstract] [Full Text] [Related]

  • 16. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
    Cuiné JF, Charman WN, Pouton CW, Edwards GA, Porter CJ.
    Pharm Res; 2007 Apr 01; 24(4):748-57. PubMed ID: 17372700
    [Abstract] [Full Text] [Related]

  • 17. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
    Mosgaard MD, Sassene P, Mu H, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2015 Aug 01; 94():493-500. PubMed ID: 26159837
    [Abstract] [Full Text] [Related]

  • 18. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
    Van Speybroeck M, Williams HD, Nguyen TH, Anby MU, Porter CJ, Augustijns P.
    Mol Pharm; 2012 Sep 04; 9(9):2750-60. PubMed ID: 22870936
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.
    Devalapally H, Silchenko S, Zhou F, McDade J, Goloverda G, Owen A, Hidalgo IJ.
    J Pharm Sci; 2013 Oct 04; 102(10):3808-15. PubMed ID: 23878097
    [Abstract] [Full Text] [Related]

  • 20. Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats.
    Tønsberg H, Holm R, Mu H, Boll JB, Jacobsen J, Müllertz A.
    J Pharm Pharmacol; 2011 Jun 04; 63(6):817-24. PubMed ID: 21585380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.